Stem cell shot aims to heal stubborn leg wounds

NCT ID NCT05549609

Completed Disease control Sponsor: Xintela AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tested a single topical dose of stem cells (XSTEM-VLU) in 6 people with difficult-to-heal venous leg ulcers. The goal was to check safety and see if the treatment helps wounds close faster when added to standard care. Participants were followed for 10 weeks after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

stem cells (XSTEM-VLU)

What this could lead to

If it works, this could point toward a new treatment that helps heal stubborn leg ulcers faster.

What could go wrong

This is a very early, tiny trial (6 people) testing safety first. It may not show clear benefit, and results may not apply to everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS LEG ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENOUS LEG ULCER

Contacts and locations

Show contact details

Locations

Clinical Trial Center (CTC)

Gothenburg, SE-413 46, Sweden
Clinical Trial Consultants (CTC) Karolinska

Stockholm, SE-171 64, Sweden